Thierry B. Thaure - Net Worth and Insider Trading

Thierry B. Thaure Net Worth

The estimated net worth of Thierry B. Thaure is at least $0 dollars as of 2024-11-13. Thierry B. Thaure is the Director of Pulse Biosciences Inc and owns about 0 shares of Pulse Biosciences Inc (PLSE) stock worth over $0. Details can be seen in Thierry B. Thaure's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thierry B. Thaure has not made any transactions after 2017-05-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Thierry B. Thaure

Thierry B. Thaure Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thierry B. Thaure owns 4 companies in total, including Pulse Biosciences Inc (PLSE) , MedTech Acquisition Corp (MTAC) , and MedTech Acquisition Corp (MTACU) among others .

Click here to see the complete history of Thierry B. Thaure’s form 4 insider trades.

Insider Ownership Summary of Thierry B. Thaure

Ticker	Comapny	Transaction Date	Type of Owner
PLSE	Pulse Biosciences Inc	2017-05-12	director
MTAC	MedTech Acquisition Corp	2021-03-18	director
MTACU	MedTech Acquisition Corp	2021-03-18	director
		2021-03-18	director

Thierry B. Thaure Latest Holdings Summary

Thierry B. Thaure currently owns a total of 1 stock. Thierry B. Thaure owns 0 shares of Pulse Biosciences Inc (PLSE) as of May 12, 2017, with a value of $0.

Latest Holdings of Thierry B. Thaure

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
PLSE	Pulse Biosciences Inc	2017-05-12	0	17.65	0

Holding Weightings of Thierry B. Thaure

Thierry B. Thaure Form 4 Trading Tracker

According to the SEC Form 4 filings, Thierry B. Thaure has made a total of 0 transactions in Pulse Biosciences Inc (PLSE) over the past 5 years. The most-recent trade in Pulse Biosciences Inc is the sale of 10,000 shares on May 12, 2017, which brought Thierry B. Thaure around $244,000.

Insider Trading History of Thierry B. Thaure

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thierry B. Thaure Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thierry B. Thaure Ownership Network

Ownership Network List of Thierry B. Thaure

No Data

Ownership Network Relation of Thierry B. Thaure

Thierry B. Thaure Owned Company Details

What does Pulse Biosciences Inc do?

Who are the key executives at Pulse Biosciences Inc?

Thierry B. Thaure is the director of Pulse Biosciences Inc. Other key executives at Pulse Biosciences Inc include director & 10 percent owner Robert W Duggan , Chief Commercial Officer Kevin Patrick Danahy , and CFO & EVP Admin. and Finance Sandra A. Gardiner .

Pulse Biosciences Inc (PLSE) Insider Trades Summary

Over the past 18 months, Thierry B. Thaure made no insider transaction in Pulse Biosciences Inc (PLSE). Other recent insider transactions involving Pulse Biosciences Inc (PLSE) include a net purchase of 1,037,241 shares made by Robert W Duggan , a net purchase of 17,800 shares made by Mitchell E. Levinson , and a net purchase of 10,000 shares made by .

In summary, during the past 3 months, insiders sold 0 shares of Pulse Biosciences Inc (PLSE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pulse Biosciences Inc (PLSE) were sold and 1,070,434 shares were bought by its insiders, resulting in a net purchase of 1,070,434 shares.

Pulse Biosciences Inc (PLSE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pulse Biosciences Inc Insider Transactions

No Available Data

What does MedTech Acquisition Corp do?

Who are the key executives at MedTech Acquisition Corp?

Thierry B. Thaure is the director of MedTech Acquisition Corp. Other key executives at MedTech Acquisition Corp include President & Therapeutics Jodi Devlin , 10 percent owner Equity Ab Frankenius , and director & 10 percent owner Mats Wahlstrom .

MedTech Acquisition Corp (MTAC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MedTech Acquisition Corp (MTAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MedTech Acquisition Corp (MTAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MedTech Acquisition Corp (MTAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

MedTech Acquisition Corp Insider Transactions

No Available Data

What does MedTech Acquisition Corp do?

Who are the key executives at MedTech Acquisition Corp?

Thierry B. Thaure is the director of MedTech Acquisition Corp. Other key executives at MedTech Acquisition Corp include 10 percent owner Magnetar Financial Llc , 10 percent owner Magnetar Capital Partners Lp , and 10 percent owner Supernova Management Llc .

MedTech Acquisition Corp (MTACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MedTech Acquisition Corp (MTACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MedTech Acquisition Corp (MTACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MedTech Acquisition Corp (MTACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

MedTech Acquisition Corp Insider Transactions

No Available Data

What does TriSalus Life Sciences Inc do?

Who are the key executives at TriSalus Life Sciences Inc?

Thierry B. Thaure is the director of TriSalus Life Sciences Inc. Other key executives at TriSalus Life Sciences Inc include director & CEO and President Mary T Szela , President & Therapeutics Jodi Devlin , and 10 percent owner Equity Ab Frankenius .

TriSalus Life Sciences Inc (TLSI) Insider Trades Summary

Over the past 18 months, Thierry B. Thaure made no insider transaction in TriSalus Life Sciences Inc (TLSI). Other recent insider transactions involving TriSalus Life Sciences Inc (TLSI) include a net purchase of 19,815 shares made by Mary T Szela , and a net sale of 9 shares made by George Kelly Martin .

In summary, during the past 3 months, insiders sold 9 shares of TriSalus Life Sciences Inc (TLSI) in total and bought 19,815 shares, with a net purchase of 19,806 shares. During the past 18 months, 9 shares of TriSalus Life Sciences Inc (TLSI) were sold and 19,815 shares were bought by its insiders, resulting in a net purchase of 19,806 shares.

TriSalus Life Sciences Inc (TLSI)'s detailed insider trading history can be found in Insider Trading Tracker table.

TriSalus Life Sciences Inc Insider Transactions

No Available Data

Thierry B. Thaure Mailing Address

Above is the net worth, insider trading, and ownership report for Thierry B. Thaure. You might contact Thierry B. Thaure via mailing address: 3957 Point Eden Way, Hayward Ca 94545.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.